nodes	percent_of_prediction	percent_of_DWPC	metapath
Acarbose—MGAM—urine—urinary bladder cancer	0.0637	0.156	CbGeAlD
Acarbose—GAA—urine—urinary bladder cancer	0.0554	0.136	CbGeAlD
Acarbose—SI—prostate gland—urinary bladder cancer	0.0402	0.0984	CbGeAlD
Acarbose—AMY1B—female reproductive system—urinary bladder cancer	0.0248	0.0608	CbGeAlD
Acarbose—SI—female reproductive system—urinary bladder cancer	0.0219	0.0537	CbGeAlD
Acarbose—AMY2A—female reproductive system—urinary bladder cancer	0.02	0.0489	CbGeAlD
Acarbose—GAA—prostate gland—urinary bladder cancer	0.0199	0.0487	CbGeAlD
Acarbose—MGAM—seminal vesicle—urinary bladder cancer	0.0193	0.0473	CbGeAlD
Acarbose—GAA—seminal vesicle—urinary bladder cancer	0.0168	0.0412	CbGeAlD
Acarbose—MGAM—epithelium—urinary bladder cancer	0.0168	0.0411	CbGeAlD
Acarbose—MGAM—smooth muscle tissue—urinary bladder cancer	0.0162	0.0396	CbGeAlD
Acarbose—MGAM—renal system—urinary bladder cancer	0.0156	0.0382	CbGeAlD
Acarbose—GAA—renal system—urinary bladder cancer	0.0136	0.0332	CbGeAlD
Acarbose—GAA—urethra—urinary bladder cancer	0.0133	0.0326	CbGeAlD
Acarbose—MGAM—female reproductive system—urinary bladder cancer	0.0125	0.0306	CbGeAlD
Acarbose—MGAM—vagina—urinary bladder cancer	0.0113	0.0276	CbGeAlD
Acarbose—GAA—female reproductive system—urinary bladder cancer	0.0109	0.0266	CbGeAlD
Acarbose—GAA—vagina—urinary bladder cancer	0.00982	0.0241	CbGeAlD
Acarbose—Intestinal obstruction—Thiotepa—urinary bladder cancer	0.00648	0.028	CcSEcCtD
Acarbose—GAA—lymph node—urinary bladder cancer	0.00635	0.0156	CbGeAlD
Acarbose—Ileus—Thiotepa—urinary bladder cancer	0.00624	0.027	CcSEcCtD
Acarbose—Gastrointestinal symptom NOS—Fluorouracil—urinary bladder cancer	0.00621	0.0269	CcSEcCtD
Acarbose—Flatulence—Valrubicin—urinary bladder cancer	0.00549	0.0238	CcSEcCtD
Acarbose—Intestinal perforation—Methotrexate—urinary bladder cancer	0.00481	0.0208	CcSEcCtD
Acarbose—Liver injury—Cisplatin—urinary bladder cancer	0.00412	0.0178	CcSEcCtD
Acarbose—Erythema—Mitomycin—urinary bladder cancer	0.00384	0.0166	CcSEcCtD
Acarbose—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00372	0.0161	CcSEcCtD
Acarbose—Abdominal pain—Valrubicin—urinary bladder cancer	0.0036	0.0156	CcSEcCtD
Acarbose—Hepatocellular injury—Cisplatin—urinary bladder cancer	0.00346	0.015	CcSEcCtD
Acarbose—Oedema—Mitomycin—urinary bladder cancer	0.00313	0.0136	CcSEcCtD
Acarbose—Diarrhoea—Valrubicin—urinary bladder cancer	0.00311	0.0135	CcSEcCtD
Acarbose—Hepatic function abnormal—Gemcitabine—urinary bladder cancer	0.00309	0.0134	CcSEcCtD
Acarbose—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00307	0.0133	CcSEcCtD
Acarbose—Vomiting—Valrubicin—urinary bladder cancer	0.00289	0.0125	CcSEcCtD
Acarbose—Rash—Valrubicin—urinary bladder cancer	0.00287	0.0124	CcSEcCtD
Acarbose—Dermatitis—Valrubicin—urinary bladder cancer	0.00287	0.0124	CcSEcCtD
Acarbose—Liver disorder—Methotrexate—urinary bladder cancer	0.00279	0.0121	CcSEcCtD
Acarbose—Nausea—Valrubicin—urinary bladder cancer	0.0027	0.0117	CcSEcCtD
Acarbose—Ileus—Epirubicin—urinary bladder cancer	0.00251	0.0109	CcSEcCtD
Acarbose—Liver function test abnormal—Gemcitabine—urinary bladder cancer	0.00249	0.0108	CcSEcCtD
Acarbose—Jaundice—Thiotepa—urinary bladder cancer	0.00241	0.0104	CcSEcCtD
Acarbose—Hepatobiliary disease—Thiotepa—urinary bladder cancer	0.00234	0.0101	CcSEcCtD
Acarbose—Ileus—Doxorubicin—urinary bladder cancer	0.00232	0.0101	CcSEcCtD
Acarbose—Diarrhoea—Mitomycin—urinary bladder cancer	0.00214	0.00928	CcSEcCtD
Acarbose—Liver injury—Epirubicin—urinary bladder cancer	0.00211	0.00915	CcSEcCtD
Acarbose—Angiopathy—Thiotepa—urinary bladder cancer	0.00201	0.00871	CcSEcCtD
Acarbose—Immune system disorder—Thiotepa—urinary bladder cancer	0.002	0.00867	CcSEcCtD
Acarbose—Vomiting—Mitomycin—urinary bladder cancer	0.00199	0.00862	CcSEcCtD
Acarbose—Rash—Mitomycin—urinary bladder cancer	0.00198	0.00855	CcSEcCtD
Acarbose—Dermatitis—Mitomycin—urinary bladder cancer	0.00197	0.00854	CcSEcCtD
Acarbose—Rectal haemorrhage—Epirubicin—urinary bladder cancer	0.00197	0.00852	CcSEcCtD
Acarbose—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.00197	0.00851	CcSEcCtD
Acarbose—Liver injury—Doxorubicin—urinary bladder cancer	0.00196	0.00846	CcSEcCtD
Acarbose—Erythema—Thiotepa—urinary bladder cancer	0.00193	0.00836	CcSEcCtD
Acarbose—Nausea—Mitomycin—urinary bladder cancer	0.00186	0.00805	CcSEcCtD
Acarbose—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.00183	0.00793	CcSEcCtD
Acarbose—Rectal haemorrhage—Doxorubicin—urinary bladder cancer	0.00182	0.00788	CcSEcCtD
Acarbose—Hepatocellular injury—Epirubicin—urinary bladder cancer	0.00178	0.0077	CcSEcCtD
Acarbose—Jaundice—Etoposide—urinary bladder cancer	0.00173	0.00749	CcSEcCtD
Acarbose—Angiopathy—Gemcitabine—urinary bladder cancer	0.00169	0.00733	CcSEcCtD
Acarbose—Immune system disorder—Gemcitabine—urinary bladder cancer	0.00169	0.00729	CcSEcCtD
Acarbose—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.00168	0.00726	CcSEcCtD
Acarbose—Hepatocellular injury—Doxorubicin—urinary bladder cancer	0.00165	0.00712	CcSEcCtD
Acarbose—Erythema—Gemcitabine—urinary bladder cancer	0.00162	0.00703	CcSEcCtD
Acarbose—SI—Disease—SLC19A1—urinary bladder cancer	0.00162	0.0045	CbGpPWpGaD
Acarbose—MGAM—Disease—SLC19A1—urinary bladder cancer	0.00162	0.0045	CbGpPWpGaD
Acarbose—AMY2A—Metabolism—SLC19A1—urinary bladder cancer	0.0016	0.00444	CbGpPWpGaD
Acarbose—SI—Metabolism—UGT2B7—urinary bladder cancer	0.0016	0.00444	CbGpPWpGaD
Acarbose—MGAM—Metabolism—UGT2B7—urinary bladder cancer	0.0016	0.00444	CbGpPWpGaD
Acarbose—Erythema—Fluorouracil—urinary bladder cancer	0.0016	0.00691	CcSEcCtD
Acarbose—SI—Disease—PRSS3—urinary bladder cancer	0.00158	0.00439	CbGpPWpGaD
Acarbose—MGAM—Disease—PRSS3—urinary bladder cancer	0.00158	0.00439	CbGpPWpGaD
Acarbose—Immune system disorder—Cisplatin—urinary bladder cancer	0.00157	0.0068	CcSEcCtD
Acarbose—AMY2A—Metabolism—PRSS3—urinary bladder cancer	0.00156	0.00432	CbGpPWpGaD
Acarbose—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00154	0.00668	CcSEcCtD
Acarbose—Erythema—Cisplatin—urinary bladder cancer	0.00151	0.00655	CcSEcCtD
Acarbose—MGAM—Disease—HDAC4—urinary bladder cancer	0.00151	0.00419	CbGpPWpGaD
Acarbose—SI—Disease—HDAC4—urinary bladder cancer	0.00151	0.00419	CbGpPWpGaD
Acarbose—Flatulence—Cisplatin—urinary bladder cancer	0.00149	0.00646	CcSEcCtD
Acarbose—AMY1A—Metabolism—NAT2—urinary bladder cancer	0.00149	0.00412	CbGpPWpGaD
Acarbose—AMY1B—Metabolism—NAT2—urinary bladder cancer	0.00149	0.00412	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—NAT2—urinary bladder cancer	0.00149	0.00412	CbGpPWpGaD
Acarbose—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.00148	0.00639	CcSEcCtD
Acarbose—Angiopathy—Etoposide—urinary bladder cancer	0.00145	0.00626	CcSEcCtD
Acarbose—SI—Metabolism—CYP4B1—urinary bladder cancer	0.00144	0.00399	CbGpPWpGaD
Acarbose—MGAM—Metabolism—CYP4B1—urinary bladder cancer	0.00144	0.00399	CbGpPWpGaD
Acarbose—Immune system disorder—Etoposide—urinary bladder cancer	0.00144	0.00623	CcSEcCtD
Acarbose—AMY1A—Disease—ENO2—urinary bladder cancer	0.00142	0.00394	CbGpPWpGaD
Acarbose—AMY1B—Disease—ENO2—urinary bladder cancer	0.00142	0.00394	CbGpPWpGaD
Acarbose—AMY1C—Disease—ENO2—urinary bladder cancer	0.00142	0.00394	CbGpPWpGaD
Acarbose—AMY2A—Disease—LIG1—urinary bladder cancer	0.00141	0.00391	CbGpPWpGaD
Acarbose—Dyspepsia—Thiotepa—urinary bladder cancer	0.00139	0.006	CcSEcCtD
Acarbose—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.00137	0.00591	CcSEcCtD
Acarbose—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00136	0.00589	CcSEcCtD
Acarbose—MGAM—Metabolism—SLC19A1—urinary bladder cancer	0.00136	0.00377	CbGpPWpGaD
Acarbose—SI—Metabolism—SLC19A1—urinary bladder cancer	0.00136	0.00377	CbGpPWpGaD
Acarbose—Constipation—Thiotepa—urinary bladder cancer	0.00135	0.00583	CcSEcCtD
Acarbose—AMY1B—Disease—RBX1—urinary bladder cancer	0.00135	0.00373	CbGpPWpGaD
Acarbose—AMY1A—Disease—RBX1—urinary bladder cancer	0.00135	0.00373	CbGpPWpGaD
Acarbose—AMY1C—Disease—RBX1—urinary bladder cancer	0.00135	0.00373	CbGpPWpGaD
Acarbose—Oedema—Gemcitabine—urinary bladder cancer	0.00133	0.00574	CcSEcCtD
Acarbose—MGAM—Metabolism—PRSS3—urinary bladder cancer	0.00133	0.00368	CbGpPWpGaD
Acarbose—SI—Metabolism—PRSS3—urinary bladder cancer	0.00133	0.00368	CbGpPWpGaD
Acarbose—Oedema—Fluorouracil—urinary bladder cancer	0.0013	0.00564	CcSEcCtD
Acarbose—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.0013	0.00562	CcSEcCtD
Acarbose—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00129	0.00558	CcSEcCtD
Acarbose—AMY1C—Metabolism—RRM2—urinary bladder cancer	0.00128	0.00356	CbGpPWpGaD
Acarbose—AMY1B—Metabolism—RRM2—urinary bladder cancer	0.00128	0.00356	CbGpPWpGaD
Acarbose—AMY1A—Metabolism—RRM2—urinary bladder cancer	0.00128	0.00356	CbGpPWpGaD
Acarbose—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00128	0.00552	CcSEcCtD
Acarbose—Liver function test abnormal—Methotrexate—urinary bladder cancer	0.00127	0.00551	CcSEcCtD
Acarbose—Urticaria—Thiotepa—urinary bladder cancer	0.00125	0.00542	CcSEcCtD
Acarbose—AMY2A—Metabolism—TYMP—urinary bladder cancer	0.00125	0.00346	CbGpPWpGaD
Acarbose—Abdominal pain—Thiotepa—urinary bladder cancer	0.00125	0.00539	CcSEcCtD
Acarbose—Oedema—Cisplatin—urinary bladder cancer	0.00124	0.00535	CcSEcCtD
Acarbose—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00121	0.00524	CcSEcCtD
Acarbose—AMY1C—Disease—JAG1—urinary bladder cancer	0.0012	0.00334	CbGpPWpGaD
Acarbose—AMY1A—Disease—JAG1—urinary bladder cancer	0.0012	0.00334	CbGpPWpGaD
Acarbose—AMY1B—Disease—JAG1—urinary bladder cancer	0.0012	0.00334	CbGpPWpGaD
Acarbose—SI—Disease—LIG1—urinary bladder cancer	0.0012	0.00333	CbGpPWpGaD
Acarbose—MGAM—Disease—LIG1—urinary bladder cancer	0.0012	0.00333	CbGpPWpGaD
Acarbose—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.00119	0.00516	CcSEcCtD
Acarbose—AMY1B—Metabolism—HPGDS—urinary bladder cancer	0.00119	0.0033	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—HPGDS—urinary bladder cancer	0.00119	0.0033	CbGpPWpGaD
Acarbose—AMY1A—Metabolism—HPGDS—urinary bladder cancer	0.00119	0.0033	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—ENO2—urinary bladder cancer	0.00119	0.0033	CbGpPWpGaD
Acarbose—AMY1B—Metabolism—ENO2—urinary bladder cancer	0.00119	0.0033	CbGpPWpGaD
Acarbose—AMY1A—Metabolism—ENO2—urinary bladder cancer	0.00119	0.0033	CbGpPWpGaD
Acarbose—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00116	0.00502	CcSEcCtD
Acarbose—AMY1B—Metabolism—GSTT1—urinary bladder cancer	0.00115	0.0032	CbGpPWpGaD
Acarbose—AMY1A—Metabolism—GSTT1—urinary bladder cancer	0.00115	0.0032	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—GSTT1—urinary bladder cancer	0.00115	0.0032	CbGpPWpGaD
Acarbose—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00115	0.00496	CcSEcCtD
Acarbose—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00114	0.00495	CcSEcCtD
Acarbose—Constipation—Gemcitabine—urinary bladder cancer	0.00113	0.00491	CcSEcCtD
Acarbose—AMY2A—Metabolism—NAT2—urinary bladder cancer	0.00113	0.00313	CbGpPWpGaD
Acarbose—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00113	0.00487	CcSEcCtD
Acarbose—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00111	0.0048	CcSEcCtD
Acarbose—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.0011	0.00477	CcSEcCtD
Acarbose—Diarrhoea—Thiotepa—urinary bladder cancer	0.00108	0.00467	CcSEcCtD
Acarbose—AMY2A—Disease—ENO2—urinary bladder cancer	0.00108	0.00298	CbGpPWpGaD
Acarbose—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00107	0.00462	CcSEcCtD
Acarbose—MGAM—Metabolism—TYMP—urinary bladder cancer	0.00106	0.00294	CbGpPWpGaD
Acarbose—SI—Metabolism—TYMP—urinary bladder cancer	0.00106	0.00294	CbGpPWpGaD
Acarbose—Urticaria—Fluorouracil—urinary bladder cancer	0.00104	0.00448	CcSEcCtD
Acarbose—AMY2A—Disease—RBX1—urinary bladder cancer	0.00102	0.00283	CbGpPWpGaD
Acarbose—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.00101	0.00435	CcSEcCtD
Acarbose—Vomiting—Thiotepa—urinary bladder cancer	0.001	0.00434	CcSEcCtD
Acarbose—Rash—Thiotepa—urinary bladder cancer	0.000994	0.0043	CcSEcCtD
Acarbose—Dermatitis—Thiotepa—urinary bladder cancer	0.000993	0.0043	CcSEcCtD
Acarbose—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000977	0.00423	CcSEcCtD
Acarbose—AMY2A—Metabolism—RRM2—urinary bladder cancer	0.000973	0.0027	CbGpPWpGaD
Acarbose—Jaundice—Epirubicin—urinary bladder cancer	0.00097	0.0042	CcSEcCtD
Acarbose—Constipation—Etoposide—urinary bladder cancer	0.000968	0.00419	CcSEcCtD
Acarbose—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00096	0.00416	CcSEcCtD
Acarbose—AMY1B—Metabolism—NQO1—urinary bladder cancer	0.000958	0.00266	CbGpPWpGaD
Acarbose—AMY1A—Metabolism—NQO1—urinary bladder cancer	0.000958	0.00266	CbGpPWpGaD
Acarbose—MGAM—Metabolism—NAT2—urinary bladder cancer	0.000958	0.00266	CbGpPWpGaD
Acarbose—SI—Metabolism—NAT2—urinary bladder cancer	0.000958	0.00266	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—NQO1—urinary bladder cancer	0.000958	0.00266	CbGpPWpGaD
Acarbose—Hepatitis—Methotrexate—urinary bladder cancer	0.000954	0.00413	CcSEcCtD
Acarbose—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000941	0.00407	CcSEcCtD
Acarbose—Nausea—Thiotepa—urinary bladder cancer	0.000936	0.00405	CcSEcCtD
Acarbose—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000926	0.00401	CcSEcCtD
Acarbose—SI—Disease—ENO2—urinary bladder cancer	0.000915	0.00254	CbGpPWpGaD
Acarbose—MGAM—Disease—ENO2—urinary bladder cancer	0.000915	0.00254	CbGpPWpGaD
Acarbose—AMY2A—Disease—JAG1—urinary bladder cancer	0.000913	0.00253	CbGpPWpGaD
Acarbose—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00091	0.00394	CcSEcCtD
Acarbose—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000907	0.00392	CcSEcCtD
Acarbose—AMY2A—Metabolism—ENO2—urinary bladder cancer	0.000901	0.0025	CbGpPWpGaD
Acarbose—AMY2A—Metabolism—HPGDS—urinary bladder cancer	0.000901	0.0025	CbGpPWpGaD
Acarbose—Urticaria—Etoposide—urinary bladder cancer	0.000899	0.00389	CcSEcCtD
Acarbose—Jaundice—Doxorubicin—urinary bladder cancer	0.000897	0.00388	CcSEcCtD
Acarbose—Abdominal pain—Etoposide—urinary bladder cancer	0.000895	0.00387	CcSEcCtD
Acarbose—Hepatitis—Epirubicin—urinary bladder cancer	0.000893	0.00386	CcSEcCtD
Acarbose—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000892	0.00386	CcSEcCtD
Acarbose—AMY1A—Disease—NCOR1—urinary bladder cancer	0.000877	0.00243	CbGpPWpGaD
Acarbose—AMY1B—Disease—NCOR1—urinary bladder cancer	0.000877	0.00243	CbGpPWpGaD
Acarbose—AMY1C—Disease—NCOR1—urinary bladder cancer	0.000877	0.00243	CbGpPWpGaD
Acarbose—AMY2A—Metabolism—GSTT1—urinary bladder cancer	0.000874	0.00242	CbGpPWpGaD
Acarbose—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000871	0.00377	CcSEcCtD
Acarbose—MGAM—Disease—RBX1—urinary bladder cancer	0.000867	0.0024	CbGpPWpGaD
Acarbose—SI—Disease—RBX1—urinary bladder cancer	0.000867	0.0024	CbGpPWpGaD
Acarbose—Angiopathy—Methotrexate—urinary bladder cancer	0.000866	0.00375	CcSEcCtD
Acarbose—Immune system disorder—Methotrexate—urinary bladder cancer	0.000862	0.00373	CcSEcCtD
Acarbose—Diarrhoea—Cisplatin—urinary bladder cancer	0.000845	0.00366	CcSEcCtD
Acarbose—Vomiting—Gemcitabine—urinary bladder cancer	0.000843	0.00365	CcSEcCtD
Acarbose—Rash—Gemcitabine—urinary bladder cancer	0.000836	0.00362	CcSEcCtD
Acarbose—Dermatitis—Gemcitabine—urinary bladder cancer	0.000835	0.00361	CcSEcCtD
Acarbose—Hypersensitivity—Etoposide—urinary bladder cancer	0.000834	0.00361	CcSEcCtD
Acarbose—Erythema—Methotrexate—urinary bladder cancer	0.000831	0.0036	CcSEcCtD
Acarbose—Vomiting—Fluorouracil—urinary bladder cancer	0.000829	0.00359	CcSEcCtD
Acarbose—MGAM—Metabolism—RRM2—urinary bladder cancer	0.000827	0.00229	CbGpPWpGaD
Acarbose—SI—Metabolism—RRM2—urinary bladder cancer	0.000827	0.00229	CbGpPWpGaD
Acarbose—Hepatitis—Doxorubicin—urinary bladder cancer	0.000826	0.00358	CcSEcCtD
Acarbose—AMY1A—Disease—ERCC2—urinary bladder cancer	0.000825	0.00229	CbGpPWpGaD
Acarbose—AMY1C—Disease—ERCC2—urinary bladder cancer	0.000825	0.00229	CbGpPWpGaD
Acarbose—AMY1B—Disease—ERCC2—urinary bladder cancer	0.000825	0.00229	CbGpPWpGaD
Acarbose—Rash—Fluorouracil—urinary bladder cancer	0.000822	0.00356	CcSEcCtD
Acarbose—Dermatitis—Fluorouracil—urinary bladder cancer	0.000821	0.00355	CcSEcCtD
Acarbose—Angiopathy—Epirubicin—urinary bladder cancer	0.00081	0.00351	CcSEcCtD
Acarbose—Immune system disorder—Epirubicin—urinary bladder cancer	0.000807	0.00349	CcSEcCtD
Acarbose—AMY1A—Metabolism—GSTP1—urinary bladder cancer	0.000799	0.00222	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—GSTP1—urinary bladder cancer	0.000799	0.00222	CbGpPWpGaD
Acarbose—AMY1B—Metabolism—GSTP1—urinary bladder cancer	0.000799	0.00222	CbGpPWpGaD
Acarbose—Nausea—Gemcitabine—urinary bladder cancer	0.000787	0.00341	CcSEcCtD
Acarbose—Vomiting—Cisplatin—urinary bladder cancer	0.000786	0.0034	CcSEcCtD
Acarbose—Rash—Cisplatin—urinary bladder cancer	0.000779	0.00337	CcSEcCtD
Acarbose—Dermatitis—Cisplatin—urinary bladder cancer	0.000778	0.00337	CcSEcCtD
Acarbose—Erythema—Epirubicin—urinary bladder cancer	0.000777	0.00336	CcSEcCtD
Acarbose—MGAM—Disease—JAG1—urinary bladder cancer	0.000776	0.00215	CbGpPWpGaD
Acarbose—SI—Disease—JAG1—urinary bladder cancer	0.000776	0.00215	CbGpPWpGaD
Acarbose—AMY1C—Disease—MTHFR—urinary bladder cancer	0.000775	0.00215	CbGpPWpGaD
Acarbose—AMY1B—Disease—MTHFR—urinary bladder cancer	0.000775	0.00215	CbGpPWpGaD
Acarbose—AMY1A—Disease—MTHFR—urinary bladder cancer	0.000775	0.00215	CbGpPWpGaD
Acarbose—Diarrhoea—Etoposide—urinary bladder cancer	0.000774	0.00335	CcSEcCtD
Acarbose—Nausea—Fluorouracil—urinary bladder cancer	0.000774	0.00335	CcSEcCtD
Acarbose—AMY1A—Disease—TERT—urinary bladder cancer	0.000773	0.00214	CbGpPWpGaD
Acarbose—AMY1B—Disease—TERT—urinary bladder cancer	0.000773	0.00214	CbGpPWpGaD
Acarbose—AMY1C—Disease—TERT—urinary bladder cancer	0.000773	0.00214	CbGpPWpGaD
Acarbose—Flatulence—Epirubicin—urinary bladder cancer	0.000766	0.00332	CcSEcCtD
Acarbose—MGAM—Metabolism—ENO2—urinary bladder cancer	0.000766	0.00212	CbGpPWpGaD
Acarbose—SI—Metabolism—ENO2—urinary bladder cancer	0.000766	0.00212	CbGpPWpGaD
Acarbose—SI—Metabolism—HPGDS—urinary bladder cancer	0.000766	0.00212	CbGpPWpGaD
Acarbose—MGAM—Metabolism—HPGDS—urinary bladder cancer	0.000766	0.00212	CbGpPWpGaD
Acarbose—Angiopathy—Doxorubicin—urinary bladder cancer	0.00075	0.00324	CcSEcCtD
Acarbose—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000746	0.00323	CcSEcCtD
Acarbose—AMY1A—Metabolism—TYMS—urinary bladder cancer	0.000743	0.00206	CbGpPWpGaD
Acarbose—MGAM—Metabolism—GSTT1—urinary bladder cancer	0.000743	0.00206	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—TYMS—urinary bladder cancer	0.000743	0.00206	CbGpPWpGaD
Acarbose—AMY1B—Metabolism—TYMS—urinary bladder cancer	0.000743	0.00206	CbGpPWpGaD
Acarbose—SI—Metabolism—GSTT1—urinary bladder cancer	0.000743	0.00206	CbGpPWpGaD
Acarbose—AMY1B—Metabolism—NCOR1—urinary bladder cancer	0.000734	0.00204	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—GSTM1—urinary bladder cancer	0.000734	0.00204	CbGpPWpGaD
Acarbose—AMY1B—Metabolism—GSTM1—urinary bladder cancer	0.000734	0.00204	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—NCOR1—urinary bladder cancer	0.000734	0.00204	CbGpPWpGaD
Acarbose—AMY1A—Metabolism—GSTM1—urinary bladder cancer	0.000734	0.00204	CbGpPWpGaD
Acarbose—AMY1A—Metabolism—NCOR1—urinary bladder cancer	0.000734	0.00204	CbGpPWpGaD
Acarbose—Nausea—Cisplatin—urinary bladder cancer	0.000734	0.00318	CcSEcCtD
Acarbose—AMY2A—Metabolism—NQO1—urinary bladder cancer	0.000726	0.00201	CbGpPWpGaD
Acarbose—Vomiting—Etoposide—urinary bladder cancer	0.00072	0.00311	CcSEcCtD
Acarbose—Erythema—Doxorubicin—urinary bladder cancer	0.000719	0.00311	CcSEcCtD
Acarbose—Rash—Etoposide—urinary bladder cancer	0.000714	0.00309	CcSEcCtD
Acarbose—Dermatitis—Etoposide—urinary bladder cancer	0.000713	0.00309	CcSEcCtD
Acarbose—AMY1A—Disease—FGFR3—urinary bladder cancer	0.000709	0.00197	CbGpPWpGaD
Acarbose—AMY1C—Disease—FGFR3—urinary bladder cancer	0.000709	0.00197	CbGpPWpGaD
Acarbose—AMY1B—Disease—FGFR3—urinary bladder cancer	0.000709	0.00197	CbGpPWpGaD
Acarbose—Flatulence—Doxorubicin—urinary bladder cancer	0.000709	0.00307	CcSEcCtD
Acarbose—AMY1A—Metabolism—GPX1—urinary bladder cancer	0.000703	0.00195	CbGpPWpGaD
Acarbose—AMY1B—Metabolism—GPX1—urinary bladder cancer	0.000703	0.00195	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—GPX1—urinary bladder cancer	0.000703	0.00195	CbGpPWpGaD
Acarbose—AMY1A—Metabolism—ERCC2—urinary bladder cancer	0.000691	0.00191	CbGpPWpGaD
Acarbose—AMY1B—Metabolism—ERCC2—urinary bladder cancer	0.000691	0.00191	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—ERCC2—urinary bladder cancer	0.000691	0.00191	CbGpPWpGaD
Acarbose—Nausea—Etoposide—urinary bladder cancer	0.000672	0.00291	CcSEcCtD
Acarbose—AMY2A—Disease—NCOR1—urinary bladder cancer	0.000665	0.00184	CbGpPWpGaD
Acarbose—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000664	0.00287	CcSEcCtD
Acarbose—AMY1C—Metabolism—MTHFR—urinary bladder cancer	0.000649	0.0018	CbGpPWpGaD
Acarbose—AMY1B—Metabolism—MTHFR—urinary bladder cancer	0.000649	0.0018	CbGpPWpGaD
Acarbose—AMY1A—Metabolism—MTHFR—urinary bladder cancer	0.000649	0.0018	CbGpPWpGaD
Acarbose—Oedema—Epirubicin—urinary bladder cancer	0.000634	0.00275	CcSEcCtD
Acarbose—AMY2A—Disease—ERCC2—urinary bladder cancer	0.000625	0.00173	CbGpPWpGaD
Acarbose—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000621	0.00269	CcSEcCtD
Acarbose—SI—Metabolism—NQO1—urinary bladder cancer	0.000617	0.00171	CbGpPWpGaD
Acarbose—MGAM—Metabolism—NQO1—urinary bladder cancer	0.000617	0.00171	CbGpPWpGaD
Acarbose—AMY2A—Metabolism—GSTP1—urinary bladder cancer	0.000606	0.00168	CbGpPWpGaD
Acarbose—AMY1C—Disease—CREBBP—urinary bladder cancer	0.000604	0.00167	CbGpPWpGaD
Acarbose—AMY1A—Disease—CREBBP—urinary bladder cancer	0.000604	0.00167	CbGpPWpGaD
Acarbose—AMY1B—Disease—CREBBP—urinary bladder cancer	0.000604	0.00167	CbGpPWpGaD
Acarbose—Dyspepsia—Methotrexate—urinary bladder cancer	0.000597	0.00258	CcSEcCtD
Acarbose—AMY2A—Disease—MTHFR—urinary bladder cancer	0.000587	0.00163	CbGpPWpGaD
Acarbose—Oedema—Doxorubicin—urinary bladder cancer	0.000587	0.00254	CcSEcCtD
Acarbose—AMY2A—Disease—TERT—urinary bladder cancer	0.000586	0.00162	CbGpPWpGaD
Acarbose—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000585	0.00253	CcSEcCtD
Acarbose—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000575	0.00249	CcSEcCtD
Acarbose—MGAM—Disease—NCOR1—urinary bladder cancer	0.000565	0.00157	CbGpPWpGaD
Acarbose—SI—Disease—NCOR1—urinary bladder cancer	0.000565	0.00157	CbGpPWpGaD
Acarbose—AMY2A—Metabolism—TYMS—urinary bladder cancer	0.000563	0.00156	CbGpPWpGaD
Acarbose—Dyspepsia—Epirubicin—urinary bladder cancer	0.000559	0.00242	CcSEcCtD
Acarbose—AMY2A—Metabolism—NCOR1—urinary bladder cancer	0.000557	0.00154	CbGpPWpGaD
Acarbose—AMY2A—Metabolism—GSTM1—urinary bladder cancer	0.000557	0.00154	CbGpPWpGaD
Acarbose—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000554	0.0024	CcSEcCtD
Acarbose—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000548	0.00237	CcSEcCtD
Acarbose—AMY1A—Disease—RHOA—urinary bladder cancer	0.000546	0.00151	CbGpPWpGaD
Acarbose—AMY1C—Disease—RHOA—urinary bladder cancer	0.000546	0.00151	CbGpPWpGaD
Acarbose—AMY1B—Disease—RHOA—urinary bladder cancer	0.000546	0.00151	CbGpPWpGaD
Acarbose—Constipation—Epirubicin—urinary bladder cancer	0.000543	0.00235	CcSEcCtD
Acarbose—Urticaria—Methotrexate—urinary bladder cancer	0.000539	0.00233	CcSEcCtD
Acarbose—AMY2A—Disease—FGFR3—urinary bladder cancer	0.000538	0.00149	CbGpPWpGaD
Acarbose—Abdominal pain—Methotrexate—urinary bladder cancer	0.000536	0.00232	CcSEcCtD
Acarbose—AMY2A—Metabolism—GPX1—urinary bladder cancer	0.000533	0.00148	CbGpPWpGaD
Acarbose—MGAM—Disease—ERCC2—urinary bladder cancer	0.000531	0.00147	CbGpPWpGaD
Acarbose—SI—Disease—ERCC2—urinary bladder cancer	0.000531	0.00147	CbGpPWpGaD
Acarbose—AMY1A—Metabolism—PPARG—urinary bladder cancer	0.000526	0.00146	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—PPARG—urinary bladder cancer	0.000526	0.00146	CbGpPWpGaD
Acarbose—AMY1B—Metabolism—PPARG—urinary bladder cancer	0.000526	0.00146	CbGpPWpGaD
Acarbose—AMY2A—Metabolism—ERCC2—urinary bladder cancer	0.000523	0.00145	CbGpPWpGaD
Acarbose—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000519	0.00225	CcSEcCtD
Acarbose—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000517	0.00224	CcSEcCtD
Acarbose—MGAM—Metabolism—GSTP1—urinary bladder cancer	0.000515	0.00143	CbGpPWpGaD
Acarbose—SI—Metabolism—GSTP1—urinary bladder cancer	0.000515	0.00143	CbGpPWpGaD
Acarbose—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000507	0.00219	CcSEcCtD
Acarbose—AMY1C—Metabolism—CREBBP—urinary bladder cancer	0.000506	0.0014	CbGpPWpGaD
Acarbose—AMY1B—Metabolism—CREBBP—urinary bladder cancer	0.000506	0.0014	CbGpPWpGaD
Acarbose—AMY1A—Metabolism—CREBBP—urinary bladder cancer	0.000506	0.0014	CbGpPWpGaD
Acarbose—AMY1C—Disease—ERBB2—urinary bladder cancer	0.000506	0.0014	CbGpPWpGaD
Acarbose—AMY1B—Disease—ERBB2—urinary bladder cancer	0.000506	0.0014	CbGpPWpGaD
Acarbose—AMY1A—Disease—ERBB2—urinary bladder cancer	0.000506	0.0014	CbGpPWpGaD
Acarbose—Urticaria—Epirubicin—urinary bladder cancer	0.000504	0.00218	CcSEcCtD
Acarbose—Constipation—Doxorubicin—urinary bladder cancer	0.000502	0.00217	CcSEcCtD
Acarbose—Abdominal pain—Epirubicin—urinary bladder cancer	0.000502	0.00217	CcSEcCtD
Acarbose—Hypersensitivity—Methotrexate—urinary bladder cancer	0.0005	0.00216	CcSEcCtD
Acarbose—MGAM—Disease—MTHFR—urinary bladder cancer	0.000499	0.00138	CbGpPWpGaD
Acarbose—SI—Disease—MTHFR—urinary bladder cancer	0.000499	0.00138	CbGpPWpGaD
Acarbose—SI—Disease—TERT—urinary bladder cancer	0.000498	0.00138	CbGpPWpGaD
Acarbose—MGAM—Disease—TERT—urinary bladder cancer	0.000498	0.00138	CbGpPWpGaD
Acarbose—AMY1A—Disease—PTGS2—urinary bladder cancer	0.000494	0.00137	CbGpPWpGaD
Acarbose—AMY1B—Disease—PTGS2—urinary bladder cancer	0.000494	0.00137	CbGpPWpGaD
Acarbose—AMY1C—Disease—PTGS2—urinary bladder cancer	0.000494	0.00137	CbGpPWpGaD
Acarbose—AMY2A—Metabolism—MTHFR—urinary bladder cancer	0.000492	0.00136	CbGpPWpGaD
Acarbose—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00048	0.00208	CcSEcCtD
Acarbose—MGAM—Metabolism—TYMS—urinary bladder cancer	0.000479	0.00133	CbGpPWpGaD
Acarbose—SI—Metabolism—TYMS—urinary bladder cancer	0.000479	0.00133	CbGpPWpGaD
Acarbose—MGAM—Metabolism—GSTM1—urinary bladder cancer	0.000473	0.00131	CbGpPWpGaD
Acarbose—SI—Metabolism—NCOR1—urinary bladder cancer	0.000473	0.00131	CbGpPWpGaD
Acarbose—SI—Metabolism—GSTM1—urinary bladder cancer	0.000473	0.00131	CbGpPWpGaD
Acarbose—MGAM—Metabolism—NCOR1—urinary bladder cancer	0.000473	0.00131	CbGpPWpGaD
Acarbose—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000467	0.00202	CcSEcCtD
Acarbose—Urticaria—Doxorubicin—urinary bladder cancer	0.000466	0.00202	CcSEcCtD
Acarbose—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000464	0.00201	CcSEcCtD
Acarbose—Diarrhoea—Methotrexate—urinary bladder cancer	0.000464	0.00201	CcSEcCtD
Acarbose—AMY2A—Disease—CREBBP—urinary bladder cancer	0.000458	0.00127	CbGpPWpGaD
Acarbose—SI—Disease—FGFR3—urinary bladder cancer	0.000457	0.00127	CbGpPWpGaD
Acarbose—MGAM—Disease—FGFR3—urinary bladder cancer	0.000457	0.00127	CbGpPWpGaD
Acarbose—MGAM—Metabolism—GPX1—urinary bladder cancer	0.000453	0.00126	CbGpPWpGaD
Acarbose—SI—Metabolism—GPX1—urinary bladder cancer	0.000453	0.00126	CbGpPWpGaD
Acarbose—MGAM—Metabolism—ERCC2—urinary bladder cancer	0.000445	0.00123	CbGpPWpGaD
Acarbose—SI—Metabolism—ERCC2—urinary bladder cancer	0.000445	0.00123	CbGpPWpGaD
Acarbose—Diarrhoea—Epirubicin—urinary bladder cancer	0.000434	0.00188	CcSEcCtD
Acarbose—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000433	0.00187	CcSEcCtD
Acarbose—AMY1B—Disease—CDKN1A—urinary bladder cancer	0.000432	0.0012	CbGpPWpGaD
Acarbose—AMY1A—Disease—CDKN1A—urinary bladder cancer	0.000432	0.0012	CbGpPWpGaD
Acarbose—AMY1C—Disease—CDKN1A—urinary bladder cancer	0.000432	0.0012	CbGpPWpGaD
Acarbose—AMY1B—Disease—PTEN—urinary bladder cancer	0.000431	0.0012	CbGpPWpGaD
Acarbose—AMY1A—Disease—PTEN—urinary bladder cancer	0.000431	0.0012	CbGpPWpGaD
Acarbose—AMY1C—Disease—PTEN—urinary bladder cancer	0.000431	0.0012	CbGpPWpGaD
Acarbose—Vomiting—Methotrexate—urinary bladder cancer	0.000431	0.00187	CcSEcCtD
Acarbose—Rash—Methotrexate—urinary bladder cancer	0.000427	0.00185	CcSEcCtD
Acarbose—Dermatitis—Methotrexate—urinary bladder cancer	0.000427	0.00185	CcSEcCtD
Acarbose—SI—Metabolism—MTHFR—urinary bladder cancer	0.000418	0.00116	CbGpPWpGaD
Acarbose—MGAM—Metabolism—MTHFR—urinary bladder cancer	0.000418	0.00116	CbGpPWpGaD
Acarbose—AMY1A—Metabolism—PTGS2—urinary bladder cancer	0.000414	0.00115	CbGpPWpGaD
Acarbose—AMY1B—Metabolism—PTGS2—urinary bladder cancer	0.000414	0.00115	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—PTGS2—urinary bladder cancer	0.000414	0.00115	CbGpPWpGaD
Acarbose—AMY2A—Disease—RHOA—urinary bladder cancer	0.000414	0.00115	CbGpPWpGaD
Acarbose—AMY1C—Disease—EP300—urinary bladder cancer	0.000411	0.00114	CbGpPWpGaD
Acarbose—AMY1A—Disease—EP300—urinary bladder cancer	0.000411	0.00114	CbGpPWpGaD
Acarbose—AMY1B—Disease—EP300—urinary bladder cancer	0.000411	0.00114	CbGpPWpGaD
Acarbose—Vomiting—Epirubicin—urinary bladder cancer	0.000403	0.00175	CcSEcCtD
Acarbose—Nausea—Methotrexate—urinary bladder cancer	0.000403	0.00174	CcSEcCtD
Acarbose—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000402	0.00174	CcSEcCtD
Acarbose—Rash—Epirubicin—urinary bladder cancer	0.0004	0.00173	CcSEcCtD
Acarbose—AMY1C—Disease—SRC—urinary bladder cancer	0.0004	0.00111	CbGpPWpGaD
Acarbose—AMY1A—Disease—SRC—urinary bladder cancer	0.0004	0.00111	CbGpPWpGaD
Acarbose—AMY1B—Disease—SRC—urinary bladder cancer	0.0004	0.00111	CbGpPWpGaD
Acarbose—Dermatitis—Epirubicin—urinary bladder cancer	0.0004	0.00173	CcSEcCtD
Acarbose—AMY2A—Metabolism—PPARG—urinary bladder cancer	0.000399	0.00111	CbGpPWpGaD
Acarbose—SI—Disease—CREBBP—urinary bladder cancer	0.000389	0.00108	CbGpPWpGaD
Acarbose—MGAM—Disease—CREBBP—urinary bladder cancer	0.000389	0.00108	CbGpPWpGaD
Acarbose—AMY2A—Metabolism—CREBBP—urinary bladder cancer	0.000383	0.00106	CbGpPWpGaD
Acarbose—AMY2A—Disease—ERBB2—urinary bladder cancer	0.000383	0.00106	CbGpPWpGaD
Acarbose—Nausea—Epirubicin—urinary bladder cancer	0.000377	0.00163	CcSEcCtD
Acarbose—AMY2A—Disease—PTGS2—urinary bladder cancer	0.000375	0.00104	CbGpPWpGaD
Acarbose—Vomiting—Doxorubicin—urinary bladder cancer	0.000373	0.00162	CcSEcCtD
Acarbose—Rash—Doxorubicin—urinary bladder cancer	0.00037	0.0016	CcSEcCtD
Acarbose—Dermatitis—Doxorubicin—urinary bladder cancer	0.00037	0.0016	CcSEcCtD
Acarbose—AMY1A—Metabolism—PTEN—urinary bladder cancer	0.000361	0.001	CbGpPWpGaD
Acarbose—AMY1B—Metabolism—PTEN—urinary bladder cancer	0.000361	0.001	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—PTEN—urinary bladder cancer	0.000361	0.001	CbGpPWpGaD
Acarbose—AMY1C—Disease—MYC—urinary bladder cancer	0.000358	0.000994	CbGpPWpGaD
Acarbose—AMY1A—Disease—MYC—urinary bladder cancer	0.000358	0.000994	CbGpPWpGaD
Acarbose—AMY1B—Disease—MYC—urinary bladder cancer	0.000358	0.000994	CbGpPWpGaD
Acarbose—MGAM—Disease—RHOA—urinary bladder cancer	0.000352	0.000976	CbGpPWpGaD
Acarbose—SI—Disease—RHOA—urinary bladder cancer	0.000352	0.000976	CbGpPWpGaD
Acarbose—AMY1B—Disease—EGFR—urinary bladder cancer	0.00035	0.000972	CbGpPWpGaD
Acarbose—AMY1A—Disease—EGFR—urinary bladder cancer	0.00035	0.000972	CbGpPWpGaD
Acarbose—AMY1C—Disease—EGFR—urinary bladder cancer	0.00035	0.000972	CbGpPWpGaD
Acarbose—Nausea—Doxorubicin—urinary bladder cancer	0.000349	0.00151	CcSEcCtD
Acarbose—AMY1B—Metabolism—EP300—urinary bladder cancer	0.000344	0.000955	CbGpPWpGaD
Acarbose—AMY1C—Metabolism—EP300—urinary bladder cancer	0.000344	0.000955	CbGpPWpGaD
Acarbose—AMY1A—Metabolism—EP300—urinary bladder cancer	0.000344	0.000955	CbGpPWpGaD
Acarbose—SI—Metabolism—PPARG—urinary bladder cancer	0.000339	0.000941	CbGpPWpGaD
Acarbose—MGAM—Metabolism—PPARG—urinary bladder cancer	0.000339	0.000941	CbGpPWpGaD
Acarbose—AMY1B—Disease—KRAS—urinary bladder cancer	0.000331	0.000918	CbGpPWpGaD
Acarbose—AMY1A—Disease—KRAS—urinary bladder cancer	0.000331	0.000918	CbGpPWpGaD
Acarbose—AMY1C—Disease—KRAS—urinary bladder cancer	0.000331	0.000918	CbGpPWpGaD
Acarbose—AMY2A—Disease—CDKN1A—urinary bladder cancer	0.000328	0.000908	CbGpPWpGaD
Acarbose—AMY2A—Disease—PTEN—urinary bladder cancer	0.000327	0.000906	CbGpPWpGaD
Acarbose—SI—Metabolism—CREBBP—urinary bladder cancer	0.000326	0.000904	CbGpPWpGaD
Acarbose—MGAM—Metabolism—CREBBP—urinary bladder cancer	0.000326	0.000904	CbGpPWpGaD
Acarbose—MGAM—Disease—ERBB2—urinary bladder cancer	0.000326	0.000903	CbGpPWpGaD
Acarbose—SI—Disease—ERBB2—urinary bladder cancer	0.000326	0.000903	CbGpPWpGaD
Acarbose—SI—Disease—PTGS2—urinary bladder cancer	0.000319	0.000883	CbGpPWpGaD
Acarbose—MGAM—Disease—PTGS2—urinary bladder cancer	0.000319	0.000883	CbGpPWpGaD
Acarbose—AMY2A—Metabolism—PTGS2—urinary bladder cancer	0.000314	0.00087	CbGpPWpGaD
Acarbose—AMY2A—Disease—EP300—urinary bladder cancer	0.000312	0.000864	CbGpPWpGaD
Acarbose—AMY2A—Disease—SRC—urinary bladder cancer	0.000303	0.00084	CbGpPWpGaD
Acarbose—AMY1C—Disease—HRAS—urinary bladder cancer	0.000281	0.00078	CbGpPWpGaD
Acarbose—AMY1B—Disease—HRAS—urinary bladder cancer	0.000281	0.00078	CbGpPWpGaD
Acarbose—AMY1A—Disease—HRAS—urinary bladder cancer	0.000281	0.00078	CbGpPWpGaD
Acarbose—SI—Disease—CDKN1A—urinary bladder cancer	0.000278	0.000772	CbGpPWpGaD
Acarbose—MGAM—Disease—CDKN1A—urinary bladder cancer	0.000278	0.000772	CbGpPWpGaD
Acarbose—SI—Disease—PTEN—urinary bladder cancer	0.000278	0.00077	CbGpPWpGaD
Acarbose—MGAM—Disease—PTEN—urinary bladder cancer	0.000278	0.00077	CbGpPWpGaD
Acarbose—AMY2A—Metabolism—PTEN—urinary bladder cancer	0.000274	0.000759	CbGpPWpGaD
Acarbose—AMY2A—Disease—MYC—urinary bladder cancer	0.000272	0.000753	CbGpPWpGaD
Acarbose—SI—Metabolism—PTGS2—urinary bladder cancer	0.000267	0.00074	CbGpPWpGaD
Acarbose—MGAM—Metabolism—PTGS2—urinary bladder cancer	0.000267	0.00074	CbGpPWpGaD
Acarbose—AMY2A—Disease—EGFR—urinary bladder cancer	0.000266	0.000737	CbGpPWpGaD
Acarbose—MGAM—Disease—EP300—urinary bladder cancer	0.000265	0.000735	CbGpPWpGaD
Acarbose—SI—Disease—EP300—urinary bladder cancer	0.000265	0.000735	CbGpPWpGaD
Acarbose—AMY2A—Metabolism—EP300—urinary bladder cancer	0.000261	0.000724	CbGpPWpGaD
Acarbose—MGAM—Disease—SRC—urinary bladder cancer	0.000258	0.000715	CbGpPWpGaD
Acarbose—SI—Disease—SRC—urinary bladder cancer	0.000258	0.000715	CbGpPWpGaD
Acarbose—AMY2A—Disease—KRAS—urinary bladder cancer	0.000251	0.000696	CbGpPWpGaD
Acarbose—MGAM—Metabolism—PTEN—urinary bladder cancer	0.000233	0.000645	CbGpPWpGaD
Acarbose—SI—Metabolism—PTEN—urinary bladder cancer	0.000233	0.000645	CbGpPWpGaD
Acarbose—SI—Disease—MYC—urinary bladder cancer	0.000231	0.00064	CbGpPWpGaD
Acarbose—MGAM—Disease—MYC—urinary bladder cancer	0.000231	0.00064	CbGpPWpGaD
Acarbose—MGAM—Disease—EGFR—urinary bladder cancer	0.000226	0.000626	CbGpPWpGaD
Acarbose—SI—Disease—EGFR—urinary bladder cancer	0.000226	0.000626	CbGpPWpGaD
Acarbose—SI—Metabolism—EP300—urinary bladder cancer	0.000222	0.000615	CbGpPWpGaD
Acarbose—MGAM—Metabolism—EP300—urinary bladder cancer	0.000222	0.000615	CbGpPWpGaD
Acarbose—SI—Disease—KRAS—urinary bladder cancer	0.000213	0.000592	CbGpPWpGaD
Acarbose—MGAM—Disease—KRAS—urinary bladder cancer	0.000213	0.000592	CbGpPWpGaD
Acarbose—AMY2A—Disease—HRAS—urinary bladder cancer	0.000213	0.000591	CbGpPWpGaD
Acarbose—SI—Disease—HRAS—urinary bladder cancer	0.000181	0.000503	CbGpPWpGaD
Acarbose—MGAM—Disease—HRAS—urinary bladder cancer	0.000181	0.000503	CbGpPWpGaD
